全文获取类型
收费全文 | 1472363篇 |
免费 | 102001篇 |
国内免费 | 2341篇 |
专业分类
耳鼻咽喉 | 20746篇 |
儿科学 | 48304篇 |
妇产科学 | 41773篇 |
基础医学 | 215041篇 |
口腔科学 | 40059篇 |
临床医学 | 123806篇 |
内科学 | 294067篇 |
皮肤病学 | 31755篇 |
神经病学 | 116997篇 |
特种医学 | 55849篇 |
外国民族医学 | 457篇 |
外科学 | 221676篇 |
综合类 | 27333篇 |
现状与发展 | 1篇 |
一般理论 | 358篇 |
预防医学 | 110569篇 |
眼科学 | 33039篇 |
药学 | 111536篇 |
1篇 | |
中国医学 | 3090篇 |
肿瘤学 | 80248篇 |
出版年
2019年 | 11466篇 |
2018年 | 18317篇 |
2017年 | 13192篇 |
2016年 | 14317篇 |
2015年 | 16354篇 |
2014年 | 20942篇 |
2013年 | 32347篇 |
2012年 | 47567篇 |
2011年 | 49889篇 |
2010年 | 28125篇 |
2009年 | 25154篇 |
2008年 | 46904篇 |
2007年 | 50709篇 |
2006年 | 50169篇 |
2005年 | 49335篇 |
2004年 | 47090篇 |
2003年 | 45162篇 |
2002年 | 44132篇 |
2001年 | 62585篇 |
2000年 | 64146篇 |
1999年 | 54707篇 |
1998年 | 14944篇 |
1997年 | 13408篇 |
1996年 | 13620篇 |
1995年 | 12856篇 |
1994年 | 12204篇 |
1992年 | 43332篇 |
1991年 | 42464篇 |
1990年 | 41918篇 |
1989年 | 40530篇 |
1988年 | 37816篇 |
1987年 | 36899篇 |
1986年 | 35180篇 |
1985年 | 33484篇 |
1984年 | 24917篇 |
1983年 | 21674篇 |
1982年 | 12898篇 |
1981年 | 11344篇 |
1979年 | 23532篇 |
1978年 | 16491篇 |
1977年 | 14293篇 |
1976年 | 13463篇 |
1975年 | 14808篇 |
1974年 | 17413篇 |
1973年 | 16838篇 |
1972年 | 16005篇 |
1971年 | 14921篇 |
1970年 | 13876篇 |
1969年 | 13421篇 |
1968年 | 12566篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
971.
H Danielson A Kokkola T Kiviluoto J Sirén J Louhimo E Kivilaakso P Puolakkainen 《Scandinavian journal of surgery》2007,96(1):35-40
BACKGROUND: Clinical benefit from extended lymphadenectomy for gastric cancer remains controversial as a considerable variation exists between results of different studies. METHODS: 562 patients were treated at HUCH between 1987-2003, whereof 223 underwent gastrectomy with curative intent. Of these, 114 patients underwent subtotal/total gastrectomy with D1 (standard) lymphadenectomy and 109 patients had D2-3 (extended) lymph node dissection. The clinical outcome of these patients was analysed retrospectively. RESULTS: The incidence of surgical complications was 33.0% in D2-3 and 16.8% in D1 lymphadenectomy groups (p = 0.008). Abscess was the most common complication (11.0%) among D2-3 operated patients and haemorrhage (4.4%) in D1 group. Hospital mortality was 3.7% in D2-3 and 1.8% in D1 group (p = 0.438). The only statistically significant factor influencing the rate of complications was D2-3 lymphadenectomy (OR 2.620, 95% C.I. 1.375 to 4.991). D2-3 was associated with a longer postoperative hospital stay and operation time, greater blood loss and increased need for blood transfusions compared to D1. The 5-year survival was not statistically different between lymphadenectomy groups. CONCLUSION: It is justified to perform a D2-3 gastrectomy in Europe with a acceptable postoperative mortality but with a significant morbidity. Further studies are needed to assess the value of extended lymphadenectomy in gastric cancer. 相似文献
972.
973.
Y. Le Meur M. Büchler A. Thierry S. Caillard F. Villemain S. Lavaud I. Etienne P.-F. Westeel B. H. de Ligny L. Rostaing E. Thervet J. C. Szelag J.-P. Rérolle A. Rousseau G. Touchard P. Marquet 《American journal of transplantation》2007,7(11):2496-2503
Efficacy and safety of mycophenolate mofetil (MMF) may be optimized with individualized doses based on therapeutic monitoring of its active metabolite, mycophenolic acid (MPA). In this 12-month study, 137 renal allograft recipients from 11 French centers receiving basiliximab, cyclosporine A, MMF and corticosteroids were randomized to receive either concentration-controlled doses or fixed-dose MMF. A novel Bayesian estimator of MPA AUC based on three-point sampling was used to individualize doses on posttransplant days 7 and 14 and months 1, 3 and 6. The primary endpoint was treatment failure (death, graft loss, acute rejection and MMF discontinuation). Data from 65 patients/group were analyzed. At month 12, the concentration-controlled group had fewer treatment failures (p = 0.03) and acute rejection episodes (p = 0.01) with no differences in adverse event frequency. The MMF dose was higher in the concentration-controlled group at day 14 (p < 0.0001), month 1 (p < 0.0001) and month 3 (p < 0.01), as were median AUCs on day 14 (33.7 vs. 27.1 mg*h/L; p = 0.0001) and at month 1 (45.0 vs. 30.9 mg*h/L; p < 0.0001). Therapeutic MPA monitoring using a limited sampling strategy can reduce the risk of treatment failure and acute rejection in renal allograft recipients 12 months posttransplant with no increase in adverse events. 相似文献
974.
975.
K H Orend N Zarbis H Schelzig G Halter G Lang L Sunder-Plassmann 《European journal of vascular and endovascular surgery》2007,34(6):666-672
OBJECTIVES: To present a single centers' 7-year experience in the endovascular treatment of acute traumatic lesions of the descending thoracic aorta (ATL of the DTA). MATERIALS & METHODS: Between March 1999 and December 2006, 34 consecutive acute traumatic lesions of the descending aorta (23 men, mean age 44 years) were treated endovascularly. Stentgrafts used were TAG Excluder, Zenith TX2 and Talent. In 23 patients the Left Subclavian Artery (LSA) was covered. Mean procedural duration was 20 to 75 minutes. RESULTS: Exclusion of the rupture site was achieved in all cases with no conversion to open surgery. Overall 30-day mortality was 8.8%. Two patients died on post operative day (pod) 1 and one on pod 22 from cranial injuries. No death or neurological deficit related to the endovascular treatment was reported. Four type I endoleaks required treatment either by balloon reexpansion (n=2) or by additional stentgraft implantation (n=2). In two patients the stentgraft collapsed totally several days postoperatively. Two patients required secondary surgical procedures (iliac access complication and revascularisation of the left subclavian artery n=1). The average follow-up was 43.8 months (1-93 months). No stentgraft related abnormality has been subsequently documented. CONCLUSIONS: The endovascular treatment of ATL of the DTA may offer the best means of therapy in a polytrauma patient. 相似文献
976.
A multiply injured patient’s airway is primarily secured with a laryngeal tube by the responding EMS. For helicopter transfer the flight physician decides not to intubate the patient’s trachea. Mechanical ventilation was performed without complications. 相似文献
977.
Presentations of acute appendicitis represent an ongoing challenge to surgeons. This case of retrocaecal perforated appendicitis presented clinically as a right lumbar abscess, with the concomitant new diagnosis of type 2 diabetes mellitus in a 66-year-old male. This case emphasises the importance of an abdominal CT scan in any patient presenting with unusual sepsis near the abdomen. 相似文献
978.
979.
M. Diez L. Favaloro A. Bertolotti J. M. Burgos C. Vigliano M. P. Lastra M. J. Levin A. Arnedo C. Nagel A. G. Schijman R. R. Favaloro 《American journal of transplantation》2007,7(6):1633-1640
Heart transplantation (HTx) is a useful therapy for end‐stage Chaga? cardiomyopathy; however, Chagas reactivation remains a mayor complication. Parasitological methods offer poor diagnostic sensitivity, and use of more sensitive tools such as the Polymerase chain reaction (PCR) is usually necessary. In the present study, reactivation incidence and PCR usefulness for early reactivation diagnosis, as well as for treatment response evaluation during follow‐up, were analyzed using Strout parasite detection test, in 10 of 222 consecutive HTx patients suffering Chagas cardiomyopathy. PCR strategies targeted to minicircle sequences (kDNA, detection limit 1 parasite/ 10 mL blood) and miniexon genes (SL‐DNA, 200 parasite/10 mL) were performed to compare parasite burdens between samples. No patients received prophylactic antiprotozoal therapy (benznidazole). Five patients (50%) exhibited clinical reactivation within a mean period of 71.6 days; positive Strout results were observed in most cases presenting clinical manifestations. kDNA‐PCR was positive 38–85 days before reactivation, whereas SLDNA‐PCR became positive only 7–21 days later, revealing post‐HTx parasitic load enhancement present prior to clinical reactivation development. Reactivations were successfully treated with benznidazole and generated negative PCR results. Results observed in this study indicate the value of PCR testing for an early diagnosis of Chagas reactivation as well as for monitoring treatment efficacy. 相似文献
980.
Options for Immunologic Support of Renal Transplantation Through the HLA and Immunology Laboratories
HLA and immunology laboratories are an integral part of clinical kidney transplant programs. They assist transplant clinicians with evaluating the immunological suitability of potential recipients for transplantation and selecting donor-recipient combinations with a low risk of immunological failure. With sophisticated new techniques becoming available for posttransplant immunological monitoring, laboratories play an increasing supporting role during posttransplant follow up. The level of precision at which immunological testing predicts clinical outcome, however, leaves room for improvement. In this article, we summarize the current state of diagnostics, discuss problems, and point out promising developments. 相似文献